Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jul:164:122-129.
doi: 10.1016/j.resuscitation.2021.04.025. Epub 2021 May 5.

Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis

Mariachiara Ippolito et al. Resuscitation. 2021 Jul.

Abstract

Aim: To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR).

Methods: PubMed, EMBASE, Web of Science, bioRxiv and medRxiv were surveyed up to 8th February 2021 for studies reporting data on mortality of patients with COVID-19 after IHCA. The primary outcome sought was mortality (in-hospital or at 30 days) after IHCA with attempted CPR. Additional outcomes were the overall rate of IHCA, the rate of non-shockable presenting rhythms, the rate of ROSC and the rate of survival with favorable neurological status.

Results: Ten articles were included in the systematic review and meta-analysis, for a total of 1179 COVID-19 patients after IHCA with attempted CPR. The estimated overall mortality rate (in-hospital or at 30 days) was 89.9% (95% Predicted Interval [P.I.] 83.1%-94.2%; 1060/1179 patients; I2 = 82%). The estimated rate of non-shockable presenting rhythms was 89% (95% P.I. 82.8%-93.1%; 1022/1205 patients; I2 = 85%), and the estimated rate of ROSC was 32.9% (95% P.I. 26%-40.6%; 365/1205 patients; I2 = 82%). The estimated overall rate of survival with favorable neurological status at 30 days was 6.3% (95% P.I. 4%-9.7%; 50/851 patients; I2 = 48%). Sensitivity analysis showed that COVID-19 patients had higher risk of death after IHCA than non COVID-19 patients (OR 2.34; 95% C.I. 1.37-3.99; number of studies = 3; 1215 patients).

Conclusions: Although one of three COVID-19 patients undergoing IHCA may achieve ROSC, almost 90% may not survive at 30 days or to hospital discharge.

Keywords: COVID-19; Cardiac arrest; Mortality; cpr.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Forest plot reporting the results of the meta-analysis for mortality of COVID-19 patients undergoing in-hospital cardiac arrest with cardiopulmonary resuscitation. The figure shows the forest plots reporting the results of meta-analysis for mortality (in-hospital or at 30-day when the former was not reported) of COVID-19 patients undergoing in-hospital cardiac arrest with cardiopulmonary resuscitation.
Fig. 2
Fig. 2
Forest plots reporting the results of the meta-analysis for additional outcomes of COVID-19 patients undergoing in-hospital cardiac arrest with cardiopulmonary resuscitation. The figure shows the forest plots reporting the results of meta-analysis for non-shockable presentation rhythm (panel a), ROSC (panel b) and 30-day favorable neurological status (defined as a CPC score of 1 or 2) (panel c) of COVID-19 patients undergoing in-hospital cardiac arrest with cardiopulmonary resuscitation. In this analysis, the total number of patients in the study by Miles et al. included 12 patients tested negative for COVID-19 and 14 patients with indeterminate result at COVID-19 testing.

Comment in

References

    1. Grasselli G., Zangrillo A., Zanella A., et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–1581. - PMC - PubMed
    1. Poissy J., Goutay J., Caplan M., et al. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation. 2020;142:184–186. - PubMed
    1. Vicentini A., Masiello L., D’Amore S., et al. QTc interval and mortality in a population of SARS-2-CoV infected patients. Circ Arrhythm Electrophysiol. 2020;13 - PubMed
    1. University of Oxford. Coronavirus (COVID-19) Hospitalizations – Statistics and Research – Our World in Data. (Accessed 20 February 2021, at https://ourworldindata.org/covid-hospitalizations).
    1. Shah P., Smith H., Olarewaju A., et al. Is cardiopulmonary resuscitation futile in coronavirus disease 2019 patients experiencing in-hospital cardiac arrest? Crit Care Med. 2021;49:201–208. - PubMed